2022 Report details for project: Replacement Analytical Project
| Project name | Replacement Analytical Project - there are 3 reports for this project: 2021, 2022, 2023 |
|---|---|
| Google search | Google search on project name (opens in new window)  |
| Contracts | Contracts search (opens in new window) - under development |
| Organisation | BEIS (D1198) - see all reports for this organisation |
| Report year | 2022 (data is from September 2021) |
| Category | Infrastructure - see all reports for this category |
| Description: | The Replacement Analytical Project is a key component of the Analytical Services Programme, which provides essential services to operations on the Sellafield Site supporting 22 Programmes & approximately 200 Operational Facilities. The existing facility is 60 years old and cannot provide long-term capability so new analytical facilities need to be established. The Replacement Analytical Project has therefore been initiated to deliver future analytical capability to the Sellafield site, through a major modification of the National Nuclear Laboratory Central Laboratory. Key modifications are provision of standalone Highly Active (HA), Medium Active (MA) and Special Nuclear Material (SNM) analytical capability. A key part of the scope is the delivery of 135 Analytical Instruments which will perform the ongoing analysis required by facilities at Sellafield. Analytical Services remains essential to the delivery of high hazard reduction and remediation until the completion of the Sellafield Ltd mission. |
| DCA (RAG) | Red |
| DCA text: | Compared to financial year 20/21-Q4, the IPA's DCA rating at 21/22-Q4 increased from Amber to Red Since June 2021 due to known risks and concerns over the successful delivery of the RAP project to its 2019 Outline Business Case commitments, the RAP project undertook an Executive sponsored review of its delivery schedule and cost estimate to completion. This work produced its first unassured outputs in November 2021. Initial output has indicated a project completion range of November 2028 - November 2031 with a most likely outturn cost of £900m to £1.1bn (nb. pre-optimisation exercise / risk modelling) comparable to the OBC P50 of £680m (fully escalated). The Executive level sponsored Challenge & Optimisation process is continuing which is reviewing the scope, constraints, risks and execution approach in order to potentially reduce the schedule and cost. The output from the activities underway will drive the most up-to-date assessment of cost and schedule outturn, providing a first updated forecast output in July 2022, and inform the activities required to realise the opportunities ahead of the next formal sanction gate (the FBC) around July 2024. |
| Start date | 2016-09-26 |
| End date | 2028-07-10 |
| Schedule text | Compared to 2021-Q4, your project end-date remained scheduled to finish on 10 JUL 2028 This is primarily due to the following factors: The baseline end date is 10th July 2028. However, the latest forecast of 9th Nov 2028 for completion of project support to active commissioning reflects a 4 month slippage from the Outline Business Case and baseline date, with the significant factors being the impact of COVID, resource recruitment/retention issues and supply chain contract delays. Given the early maturity of the project in the detailed design phase and typically for projects at this stage, the lifetime schedule for future phases is not underpinned and is likely to change as the project matures. Latest forecast range for project end date, pre-optimisation exercise and risk modelling is November 2028 to November 2031. |
| Baseline | £53.48m |
| Forecast | £44.39m |
| Variance | -17.00% |
| Variance text: | The budget of £53.48m represents the planned scope to be delivered against the plan put in place in 2019 based on the OBC, which compares to a forecast of actual scope to be delivered of £35.53m, at a cost of £44.39m. The project has delivered less scope than originally planned due to performance issues including the multiple impacts of COVID; design deliverables delayed due to revised working arrangements and restrictions, limited site access causing delays to early construction enabling works, resource recruitment/retention issues and delays placing supply chain contracts. The actual scope delivered has cost more than planned primarily due to performance issues including the impact of COVID resulting in reduced productivity and inefficient working. |
| Whole Life Cost | £648.00m |
| WLCost text: | Compared to2021-Q4, the projects Baseline Whole Life Cost increased from 643.54 (£m) to 647.67 (£m). This is primarily due to the following factors: The current baseline of £647.67m reflects the P50 (a probability of 50% to deliver for the cost) cost profile in the Outline Business Case, escalated into 2021/22money values and incorporating the cumulative positive cost variance up to 2018/19. Given the relative immaturity of the project the P80 (a probability of 80% to deliver for the cost) is £800M and the upper range is £1Bn from the Outline Business Case in 2019/20 money values (P80 fully escalated is £878m). Latest forecast project P50 cost range, pre optimisation exercise and risk modelling, is £900m to £1.1bn |
| Notes1: | |
| Notes2: | |
| Sourcefile | IPA_2022.csv |
Home Selection Search All Reports Projects +dates Projects +costs Organisations Years Categories
Acknowledgement: GMPP data has been re-used under the Open Government Licence.